[Lecture Report] The 7th NIKKEI FT Communicable Diseases Conference – Strategies for Coexisting with Communicable Diseases: Japanese PPP Initiative through Technological Innovation- (The NIKKEI, November 6-7, 2020, Yokohama City, Kanagawa Prefecture)
date : 11/27/2020
On November 6 and 7, 2020, HGPI Chairman Dr. Kiyoshi Kurokawa and HGPI CEO and Board Member Mr. Ryoji Noritake spoke at various programs throughout both days of the 7th NIKKEI FT Communicable Diseases Conference, which was entitled “Strategies for Coexisting with Communicable Diseases: Japanese PPP Initiative through Technological Innovation.” The event was co-hosted by the NIKKEI and the Financial Times.
For details, please visit the event website, which can be found here.
Below is an excerpt from the program that included Dr. Kurokawa and Mr. Noritake. The full speaker list can be viewed here.
Friday, November 6, 2020
Lunch Session- BD Japan: The role of testing in communicable diseases~Learning from COVID-19
Moderator: Ryoji Noritake (HGPI Board Member and CEO)
Breakout Session A-1: Challenges and Efforts to Address the Threat of Infectious Diseases – Learning from the Cases of AMR and COVID-19
Discusser: Ryoji Noritake (HGPI Board Member and CEO)
Breakout Session A-2: Challenges and Efforts to Address the Threat of Infectious Diseases – Learning from the Cases of AMR and COVID-19
Discusser: Ryoji Noritake (HGPI Board Member and CEO)
Saturday, November 7, 2020
Keynote Session- Dr. Yasuhiro Suzuki, Former Vice-Minister for Health/Chief Medical & Global Health Officer, MHLW, Japan
Discusser: Kiyoshi Kurokawa (HGPI Chairman)
Special Session III: Speeches from Governors
Moderator: Ryoji Noritake (HGPI Board Member and CEO)
Special Session III: Speeches from Governors
Moderator: Ryoji Noritake (HGPI Board Member and CEO)
Agenda6- Coexisting with COVID-19 ~The Role of Japanese Initiatives
Moderator: Ryoji Noritake (HGPI Board Member and CEO)
Discusser: Kiyoshi Kurokawa (HGPI Chairman)
Summary Session
Discusser: Ryoji Noritake (HGPI Board Member and CEO)
Conclusion/Statement
Discusser: Ryoji Noritake (HGPI Board Member and CEO)
Top Research & Recommendations Posts
- [Policy Recommendations] The Path to a Sustainable Healthcare System: Three Key Objectives for Public Deliberation (January 22, 2026)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Research Report] AMR Policy Update #4: Cancer Care and AMR (Part 1)
- [Public Comment Submission] “Assessment Report on Climate Change Impacts in Japan (Draft Overview)” (December 24, 2025)
- [Research Report] The Public Opinion Survey on Child-Rearing in Modern Japan (Final Report) (March 4, 2022)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Policy Recommendations] Achieving Equity in Multidisciplinary Pain Treatment and Support Systems for Pain Management (March 31, 2023)
Featured Posts
-
2026-01-09
[Registration Open] (Hybrid Format) Dementia Project FY2025 Initiative Concluding Symposium “The Future of Dementia Policy Surrounding Families and Others Who Care for People with Dementia” (March 9, 2026)
-
2026-02-05
[Registration Open] (Webinar) The 141st HGPI Seminar “Current Status and Future Prospects of Korea’s Obesity Policy: Voices of People with Lived Experience in Policy Promotion” (March 3, 2026)







